8-K
false0001803901000000001803901us-gaap:CommonStockMember2022-01-122022-01-120001803901talk:WarrantsMember2022-01-122022-01-1200018039012022-01-122022-01-12

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 12, 2022

 

 

Talkspace, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

 

 

 

 

 

Delaware

 

001-39314

 

84-4636604

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

 

Address Not Applicable

 

Address Not Applicable

(Address of principal executive offices)

 

(Zip Code)

 

(212) 284-7206

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

 

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common stock, $0.0001 par value per share

 

TALK

 

Nasdaq Global Select Market

Warrants to purchase common stock

 

TALKW

 

Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 


 

Item 2.02. Results of Operations and Financial Condition.

 

On January 12, 2022, Talkspace, Inc. (the “Company”) announced preliminary unaudited financial results for the fourth quarter and fiscal year ended December 31, 2021. The full text of the corporate slide presentation including such financial information is attached as Exhibit 99.1 to this Current Report on Form 8-K. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

 

The information contained in Item 2.02 of this Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit

Number

 

Description

99.1

 

Corporate Slide Presentation of the Company, dated January 12, 2022

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Talkspace, Inc.

 

 

 

 

Date:

January 12, 2022

By:

/s/ Jennifer Fulk

 

 

 

Chief Financial Officer

 


Slide 1

JANUARY 13TH 2022 Talkspace: Accessible, High-Quality Mental Healthcare Doug Braunstein, Interim CEO Jennifer Fulk, CFO 40th Annual J.P. Morgan Healthcare Conference


Slide 2

Talkspace, Inc. (the “Company”) reports its financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). The select preliminary, unaudited results described in this presentation are estimates only and are subject to revision until the Company reports its full financial and business results for the quarter and year ended December 31, 2021. These estimates are not a comprehensive statement of the Company’s financial results for the fourth quarter and fiscal year ended December 31, 2021 and actual results may differ materially from these estimates as a result of the completion of year-end accounting procedures and adjustments, including the execution of the Company’s internal control over financial reporting, the completion of the preparation and audit of the Company’s financial statements and the subsequent occurrence or identification of events prior to the formal issuance of the audited financial statements for fiscal 2021. In addition, the preliminary, unaudited results described in this presentation, including revenue, B2B covered lives, and cash balance, should not be relied upon as an indicator of overall quarterly and year-end financial results, which depend on a variety of factors, including the cost of goods sold and operating expenses, among others. This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, business strategy and plans, market opportunity and expansion and objectives of our management for future operations. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast”, “future”, “intend,” “may,” “might”, “opportunity”, “plan,” “possible”, “potential,” “predict,” “project,” “should,” “strategy”, “strive”, “target,” “will,” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: our history of losses; the rapid evolution of our business and the markets in which we operate; our ability to continue growing at the rates we have historically grown, or at all; the development of the virtual behavioral health market; COVID-19 and its impact on business and economic conditions; competition in our industry; and our relationships with affiliated professional entities to provide physician and other professional services. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in under the caption “Risk Factors” in our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021 filed with the Securities and Exchange Commission (“SEC”) on November 15, 2021 and in our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. We do not give any assurance that we will achieve our expectations. Certain information contained in this presentation relate to or are based on studies, publications, surveys and other data obtained from third-party sources and the Company’s own internal estimates and research. While the Company believes these third-party sources to be reliable as of the date of this presentation, it has not independently verified, and makes no representation as to the adequacy, fairness, accuracy or completeness of, any information obtained from third-party sources, and you are urged not to give undue weight to such third-party information. While the Company believes its internal research is reliable, such research has not been verified by any independent source. Disclaimer


Slide 3

Full-Stack Behavioral Health Platform With Proven Clinical and Tech Capabilities Full-stack behavioral health platform to serve sizable, underpenetrated, and growing TAM Network of licensed therapists, psychiatrists, and prescribers addressing a wide spectrum of specialties Growing B2B business with multiple drivers to increase market penetration and enhance profitability Solid brand to leverage across multiple distribution channels Integrated machine learning model to drive member engagement and improve clinical efficacy Strong balance sheet, which we believe enables investments to accelerate revenue growth and boost cash flow


Slide 4

1 https://www.cdc.gov/nchs/covid19/pulse/mental-health.htm 2 https://www.fortunebusinessinsights.com/u-s-behavioral-health-market-105298 3 Source: SilverCloud 2021 Survey Sizable, Underpenetrated and Growing TAM Virtual BH Preferred Delivery Projected U.S. Market Growth2 >30% U.S. adults experienced symptoms of anxiety or depression as of Fall 20211 Widespread and Growing Incidence +4.7% CAGR 78% Estimated number of behavioral health consumers that prefer virtual delivery over in-person3


Slide 5

Leading Virtual Behavioral Health Provider Health Plans Employers Academic and government institutions We support Consumers, employers, and payors Adults Teens Couples Medication Self-help tools Clinical outcome measures We provide Convenient, on-demand, and outcome-driven care Assessment Diagnosis Therapy Evidence-based Effective Researched We are A secure, clinical-grade, and fully virtual solution Mobile Multi-modality Private & secure


Slide 6

Note: please reference Disclaimer for any revenue and covered lives estimates 1 Midpoint of estimated 4Q ‘21E revenue range of $27.5-28.5M. 2 Midpoint of estimated FY 2021E revenue range of $112-$113M, which reflects 4Q’ 21E estimated revenue of $27.5-28.5M. 3 69M eligible lives estimated as of 12/31/2021. This is consistent with the number of covered lives disclosed in the form 8-K filed on December 21, 2021. Preliminary Financial Performance Quarterly Revenue B2C B2B USD, millions Annual Revenue USD, millions B2B Covered Lives Covered lives, millions (1) (2) (3)


Slide 7

Near-Term Priorities Grow and enhance clinical network Unify B2B2C conversion and service delivery Further resource B2B business for growth Optimize B2C marketing investment Prioritize and focus new product development and roll-out Implement more rigorous business processes to optimize cash generation over time


Slide 8

B2B Business Model Overview Provide employees direct, fully-covered access to Talkspace Client chooses which plan employees will have access to Per employee per month (“PEPM”) model: Employer pays a pre-negotiated amount per person on a monthly basis Provide employees fully-covered access to Talkspace Employees have access to a limited number of sessions Fee-for-service model: Talkspace bills EAP for each session delivered Provide insured members access to Talkspace Fee-for-service model Talkspace pre-negotiates reimbursement rates with payors Talkspace bills payors for each session delivered Members may pay a co-pay ~40% of B2B run-rate revenue1 is recurring Employee Assistance Programs (EAP) Direct-to-Employer (DTE) Managed Behavioral Health (MBH) 1Run-rate of monthly revenues estimated for December 2021.


Slide 9

Multiple Drivers of B2B Revenue Growth: MBH & EAP New Covered Lives Increased Penetration Increased Utilization Expanded Product Suite + + + Increase number of sessions per active user via product enhancement Promote user retention Convert pipeline of new partners, including regional plans Sign additional covered lives with current partners Increase share of wallet by offering existing consumer products (e.g. Psychiatry, Lasting) to insured members Activate current covered lives via B2B2C marketing and unified intake funnel Strengthen payor partnerships Significant opportunity to increase market penetration & user engagement


Slide 10

Multiple Drivers of B2B Revenue Growth: Direct-To-Employer Value-Driven Pricing Expanded Product Suite + + Demand tailwinds in 2022 have potential to drive meaningful growth in recurring profit New product bundling provides opportunities to address a wide spectrum of care Differentiated product suite vis-a-vis peers Pipeline of renewals and new partnerships Continued customer inbounds Marketplace currently allows for opportunities to optimize revenue New Employer Logos


Slide 11

Applications — Individual and couples: self-guided therapy Live classes & workshops Clinical tools, including: Therapeutic exercises Worksheets Self-Help Therapy Psychiatry Multiple therapy subscription options, including treatment for: Individuals Couples Teens Multiple modalities, including: Text Video Audio messaging Live chat Starting at $30/month Starting at $260/month Starting at $125/month* Psychiatry services, including Evaluations Follow-ups Psychiatric medication management *Price for follow-up visits B2C Full Spectrum of Care


Slide 12

Path To Optimize B2C Returns Enhance Value Proposition Increase Conversion Improve Retention Pricing Shift to value-based pricing Better match customer demand with clinician availability on a state-by-state basis Merchandising Seek customer feedback to improve products, plans, and prices Increase amount of bundled offerings Continue investing in product innovation Enhance user purchasing experience Optimize and unify B2C & B2B intake funnels Superbill adoption Media Upgrades Accelerate organic content development Launch & hone omnimedia campaigns Upgrade affiliate platform Increase media efficiencies Optimize user experience Enhance user onboarding experience with focus on therapeutic connection Increase number and efficacy of clinical tools for providers Clinical Network Grow hybrid network Enhance provider training and experience


Slide 13

Digitally-native technology platform and machine learning capabilities enable enhanced care throughout the clinical journey Technology Leveraged At Every Step Match Screening / Intake Robust, data-supported provider network Data-driven funnel and conversion optimization Proprietary user matching and switching algorithm Treatment Outcomes Outcome trends and engagement patterns Clinical mentor app drives continuous quality improvement Discharge Clinical progress tracker and data-driven discharge results Personal digital care exercises and self-help tools Maintenance 1 2 3 4 5 6 Information retrieval model creates automated patient session highlights Client engagement monitoring Crisis risk alerts Machine Learning-assisted diagnosis


Slide 14

Key Takeaways Full-stack behavioral health platform to serve sizable, underpenetrated, and growing TAM Solid brand to leverage across multiple distribution channels Strong balance sheet, which we believe enables investments to accelerate revenue growth and boost cash flow Integrated machine learning model to drive member engagement and improve clinical efficacy Growing B2B business with multiple drivers to increase market penetration and enhance profitability Network of licensed clinicians addressing a wide spectrum of specialties